Sector revisions Vanda Pharmaceuticals Inc.

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 09/07/2025 BST			5-day change	1st Jan Change
5.020 ^USD	+3.29%		+7.26%	+4.80%

06-30	Vanda Pharmaceuticals Inc.(NasdaqGM:VNDA) added to Russell 2000 Value-Defensive Index	CI
06-30	Vanda Pharmaceuticals Inc.(NasdaqGM:VNDA) added to Russell 2000 Defensive Index	CI

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility (Composite)	Nbr of analysts
	VANDA PHARMACEUTICALS INC.							3
	ARGENX SE							16
	WUXI APPTEC CO., LTD.							18
	BIONTECH SE							21
	INSMED INCORPORATED							18
	SUMMIT THERAPEUTICS INC.							9
	WUXI BIOLOGICS (CAYMAN) INC.							26
	GENMAB A/S							16
	AKESO, INC.							20
	EXELIXIS, INC.							19
	SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.							16
	VERONA PHARMA PLC							11
	LEGEND BIOTECH CORPORATION							20
	MADRIGAL PHARMACEUTICALS, INC.							14
	PHARMAESSENTIA CORPORATION							4
	SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.							2
	BIOCON LIMITED							20
	NUVALENT, INC.							10
	REMEGEN CO., LTD.							15
	Average							15
	Weighted average by Cap.							17